Pneumococcal conjugate second or third-dose vaccines (PCVc) in Montenegro
Montenegro: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 28.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Montenegro, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Montenegro is 28.0%, measured in 2025. That is the highest value across all 18 years on record.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Montenegro peaked at 28.0% in 2025 and was at its lowest, 0.0%, in 2008.
That places Montenegro 162nd out of 194 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Montenegro, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 0.0% | — |
| 2020 | 0.0% | — |
| 2021 | 0.0% | — |
| 2022 | 0.0% | — |
| 2023 | 0.0% | — |
| 2024 | 0.0% | — |
| 2025 | 28.0% | — |
Montenegro compared with similar countries
- Montenegro's 28.0% is below the median for upper middle income countries, which is 76.0%, 37% of the median. (57 countries reporting)
- Montenegro's 28.0% is below the median for Europe & Central Asia, which is 87.0%, 32% of the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 0.0% | 0.0% | 0.0% | 10 |
| 2020s | 4.7% | 0.0% | 28.0% | 6 |
Countries ranked near Montenegro
More health data for Montenegro
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1184 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,522 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.07 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0271 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.97 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Montenegro?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Montenegro was 28.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Montenegro?
- The highest recorded value was 28.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Montenegro?
- The lowest recorded value was 0.0% in 2008.
- How does Montenegro rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Montenegro ranks 162nd out of 194 countries with data for 2025.
- Where does this Montenegro data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).